Study guide
17.5 Ophthalmologic, ENT & Dental Emergencies: Eye Injuries, Angle Closure, Angioedema, Epistaxis, Ear & Throat Infections and Dental Pain
BCEMP Board Certified Emergency Medicine Pharmacist Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction, Triage, and Resuscitation Fundamentals
1.1 BCEMP Exam Logistics, Content Outlines & Scoring 1.2 Emergency Triage Systems (ESI) & Pre-Hospital Care Coordination 1.3 Resuscitation Pharmacology, Pharmacokinetics & Vascular Access
2 Chapter 2: Cardiac Arrest and Dysrhythmias
2.1 Adult Cardiac Arrest & ACLS Pharmacotherapy Protocols 2.2 Acute Tachyarrhythmias: Narrow- and Wide-Complex Management 2.3 Symptomatic Bradycardia & Vasoactive Chronotropic Support 2.4 Post-Cardiac Arrest Care & Targeted Temperature Management (TTM)
3 Chapter 3: Shock and Hemodynamic Resuscitation
3.1 Sepsis & Septic Shock: Surviving Sepsis Campaign 2026 Resuscitation 3.2 Cardiogenic & Obstructive Shock, Mechanical Circulatory Support & LVADs 3.3 Hypovolemic & Hemorrhagic Shock Fluid Protocols
4 Chapter 4: Airway Management and Rapid Sequence Intubation (RSI)
4.1 Rapid Sequence Intubation (RSI) Process & Pretreatment Agents 4.2 RSI Induction Agents: Pharmacology, Selection & Dosing 4.3 Neuromuscular Blocking Agents & Post-Intubation Analgosedation
5 Chapter 5: Neurocritical Care and Neurologic Emergencies
5.1 Acute Ischemic Stroke: Thrombolysis & Blood Pressure Control 5.2 Intracranial Hemorrhage & Elevated ICP Pharmacotherapy 5.3 Status Epilepticus: Tiered Emergent Anticonvulsant Therapy 5.4 Traumatic Brain Injury & Spinal Cord Emergencies
6 Chapter 6: Acute Coronary Syndromes and Acute Heart Failure
6.1 Acute Coronary Syndromes: STEMI & NSTE-ACS Pharmacotherapy 6.2 Acute Decompensated Heart Failure & Cardiogenic Pulmonary Edema 6.3 Hypertensive Crises: Emergencies, Urgencies & Target Blood Pressure
7 Chapter 7: Pulmonary and Allergic Emergencies
7.1 Acute Pulmonary Embolism: Risk Stratification & Thrombolytic Therapy 7.2 Severe Asthma Exacerbation & COPD Acute Management 7.3 Anaphylaxis & Severe Allergic Reactions: Acute Epinephrine Protocols
8 Chapter 8: Clinical Toxicology: Approach to Poisoning and Common Overdoses
8.1 Approach to the Poisoned Patient: Poison Centers, Toxidromes, Decontamination & Enhanced Elimination 8.2 Acetaminophen Overdose & N-Acetylcysteine Dosing Strategies 8.3 Salicylate Toxicity & Toxic Alcohol Management (Fomepizole) 8.4 Opioid Toxicity & Sedative-Hypnotic/Alcohol Withdrawal Syndromes 8.5 Beta-Blocker & Calcium Channel Blocker Toxicity (HIET, Calcium, Glucagon)
9 Chapter 9: Toxicology: Specialized Poisonings and Antidotes
9.1 Digoxin, Tricyclic Antidepressants & Anticholinergic Toxicity 9.2 Cyanide, Carbon Monoxide & Organophosphate/Cholinergic Toxins 9.3 Snake and Spider Envenomations & Heavy Metal Chelation 9.4 Additional Antidotes: Methemoglobinemia, Isoniazid, Sulfonylureas, Valproate, Sympathomimetics & LAST
10 Chapter 10: Hemostasis, Anticoagulant Reversal, and Hematology
10.1 DOAC & Warfarin Reversal: Specific Reversal Agents & 4F-PCC 10.2 Heparin-Induced Thrombocytopenia (HIT) & Direct Thrombin Inhibitors 10.3 Sickle Cell Vaso-Occlusive Crises & Acute Chest Syndrome
11 Chapter 11: Endocrine, Electrolyte, and Metabolic Emergencies
11.1 Diabetic Ketoacidosis (DKA) & Hyperosmolar Hyperglycemic State (HHS) 11.2 Severe Electrolyte Emergencies: Hyperkalemia & Hyponatremia 11.3 Endocrine Crises: Thyroid Storm, Myxedema Coma & Acute Adrenal Crisis 11.4 Acute Kidney Injury, Dialyzability & Drug Dosing during RRT
12 Chapter 12: Infectious Diseases and Antimicrobial Stewardship
12.1 Severe Community & Hospital-Acquired Infections in the ED 12.2 Skin & Soft Tissue, STI, and Vector-Borne Emergencies 12.3 ED Antimicrobial Stewardship & Rapid Microbiologic Diagnostics
13 Chapter 13: Special Populations: Pediatrics, Trauma, and Obstetrics
13.1 Pediatric Resuscitation, Status Epilepticus & PALS Pharmacotherapy 13.2 Trauma Pharmacotherapy: Massive Transfusion, TXA, Open Fractures, Tetanus & Burns 13.3 Obstetric & Gynecologic Emergencies: Preeclampsia, Eclampsia & PPH
14 Chapter 14: Medication Safety, ED Operations, and Disaster Preparedness
14.1 ED High-Alert Medications, Error Reporting & Technology Safeguards 14.2 ED Workflow, Transitions of Care & Boarding Patient Management 14.3 Mass Casualty Incidents, CBRNE Countermeasures & Strategic Stockpiles
15 Chapter 15: Biostatistics, Study Design, and Literature Evaluation
15.1 Biostatistics & Hypothesis Testing: Power, Errors & Interpretations 15.2 Clinical Study Designs & Measures of Effect 15.3 Literature Evaluation, Clinical Guidelines & Research Conduct in the ED
16 Chapter 16: Medical Devices, Ventilation, and Medication Delivery
16.1 Mechanical Ventilation, Noninvasive Ventilation & High-Flow Oxygen: What the Pharmacist Must Know 16.2 Vascular Access, Enteral Tubes, Drains & Extravasation Management 16.3 Infusion Pumps, Patient-Owned Devices & Medication Delivery Device Counseling
17 Chapter 17: Organ-System Emergencies: GI, GU, Oncology, Neurology, ENT, Pain, and Psychiatry
17.1 Gastrointestinal & Hepatic Emergencies: GI Bleeding, Cirrhosis Complications, Pancreatitis & Vomiting 17.2 Genitourinary Emergencies: UTI & Pyelonephritis, Renal Colic, Urinary Retention, Priapism & Scrotal Infections 17.3 Oncologic, Immunotherapy & Hematologic Emergencies: Febrile Neutropenia, TLS, Hypercalcemia, irAEs, CAR-T, Hemophilia & TTP 17.4 Headache & Neuromuscular Emergencies: Migraine, Cluster, Myasthenic Crisis, Guillain-Barré & Bell's Palsy 17.5 Ophthalmologic, ENT & Dental Emergencies: Eye Injuries, Angle Closure, Angioedema, Epistaxis, Ear & Throat Infections and Dental Pain 17.6 Acute Pain Management & Procedural Sedation and Analgesia in the ED 17.7 Psychiatric Emergencies: Severe Agitation, Serotonin Syndrome, NMS, Lithium Toxicity & Psychotropic Overdose
18 Chapter 18: Special Populations, Medication Access, and Professional Practice
18.1 Pharmacogenomics, Adverse Drug Events & High-Risk Drug Interactions in Emergency Care 18.2 Special Populations: Older Adults, Extremes of Weight, Pregnancy & Lactation, and Immunocompromised Patients 18.3 Social Determinants of Health, Health Literacy & Medication Access at ED Discharge 18.4 Healthcare Regulations & Standards: FDA, REMS, Bar Coding, DEA, CMS, EMTALA, The Joint Commission, NIOSH & USP 18.5 Formulary & Inventory Management, Drug Shortages, Antidote Stocking & Clinical Decision Support 18.6 Quality Improvement, Practice Standards & Interprofessional Collaboration (Protocols, Teamwork & Debriefing)
17.5 Ophthalmologic, ENT & Dental Emergencies: Eye Injuries, Angle Closure, Angioedema, Epistaxis, Ear & Throat Infections and Dental Pain
Key Takeaways Explain This Topic AI
Chemical eye injuries need immediate, copious irrigation until the conjunctival pH returns to neutral, before any other evaluation.
Acute angle-closure glaucoma is treated with topical timolol, an alpha-2 agonist and IV or oral acetazolamide 500 mg, adding pilocarpine once pressure starts to fall.
Contact lens wearers with corneal abrasions need antipseudomonal fluoroquinolone drops; eye patching does not help healing.
ACE inhibitor angioedema is bradykinin-mediated, so epinephrine, antihistamines and steroids help little; airway protection and permanent ACE inhibitor discontinuation are the priorities.
The ADA advises against antibiotics for dental pain or localized swelling without systemic signs; ibuprofen with acetaminophen is first-line pain relief.
Last updated: October 2026
17.5 Ophthalmologic, ENT & Dental Emergencies: Eye Injuries, Angle Closure, Angioedema, Epistaxis, Ear & Throat Infections and Dental Pain
Note
Exam scope: 2025 outline subtopic 2B8 (Pharmacotherapy for Otolaryngology and Ophthalmology). Anaphylaxis is covered in Section 7.3, and sexually transmitted infections in Section 12.2.
- Ophthalmologic Emergencies
- Chemical Eye Injury
Irrigate first, examine later. Alkali burns (lye, lime, ammonia, airbag dust) penetrate deeper than acid burns and are more dangerous.
Instill a topical anesthetic (proparacaine or tetracaine) to allow the patient to open the eye.
Irrigate with at least 1 to 2 L of normal saline or lactated Ringer's, using a Morgan lens if available. Tap water is acceptable if it is the only option.
Wait 5 to 10 minutes, then check the pH. Continue until it is neutral (about 7.0 to 7.5) , and sweep the fornices for retained particles.
Arrange urgent ophthalmology follow-up.
Acute Angle-Closure Glaucoma
Patients have a painful red eye, halos, blurred vision, headache and vomiting, with a mid-dilated, poorly reactive pupil and very high intraocular pressure.
- Drug Typical dose Role
- Timolol 0.5% 1 drop Reduces aqueous production (watch for asthma and bradycardia)
- Apraclonidine 1% or brimonidine 0.2% 1 drop Alpha-2 agonist that reduces aqueous production
Acetazolamide 500 mg IV or orally Carbonic anhydrase inhibitor; use caution in kidney disease and sickle cell disease
Pilocarpine 1 to 2% 1 drop, repeated Constricts the pupil to open the angle; works only after the pressure begins to fall, because the ischemic iris does not respond
- Mannitol 1 to 2 g/kg IV For refractory pressure elevation
- Prednisolone acetate 1% Topical Reduces inflammation
Laser peripheral iridotomy is the definitive treatment.
Drugs that can trigger angle closure in susceptible eyes:
- Anticholinergics: nebulized ipratropium, scopolamine, diphenhydramine
- Sympathomimetics
Topiramate, which causes bilateral angle closure through ciliary body swelling. Stop the topiramate; pilocarpine does not help this type and cycloplegics are used instead.
Corneal Abrasion
Topical antibiotic : erythromycin ointment or polymyxin-trimethoprim. Contact lens wearers need antipseudomonal coverage , such as ciprofloxacin, ofloxacin or moxifloxacin drops, and no lens use until healed.
Analgesia: topical NSAID drops or oral analgesics. Patching does not improve healing.
Topical anesthetics at home have traditionally been avoided because of concern for keratitis. Small randomized trials of short, supervised courses found no harm, but practice varies; never send patients home with unlimited anesthetic drops.
Serious Eye Infections and Trauma
Gonococcal conjunctivitis (hyperacute, copious discharge): ceftriaxone 1 g IM once (CDC 2021) and urgent ophthalmology.
Herpes zoster ophthalmicus: valacyclovir 1 g three times daily for 7 days, started within 72 hours, with ophthalmology follow-up. Nasal-tip lesions (Hutchinson sign) predict eye involvement.
Orbital cellulitis: IV vancomycin plus ceftriaxone (or ampicillin-sulbactam), imaging and ophthalmology review.
Open globe injury: place a rigid shield, give no topical drugs, update tetanus, give antiemetics and analgesia to prevent straining, and start IV antibiotics as directed by ophthalmology.
Avoid steroid eye drops without ophthalmology input , because they worsen herpes simplex keratitis and fungal infections.
Central Retinal Artery Occlusion
Sudden, painless, monocular vision loss is treated like a stroke. Send the patient to a stroke center urgently for vascular workup. IV thrombolysis within 4.5 hours is being studied and is considered case by case. Ocular massage and anterior chamber paracentesis have no proven benefit.
- ENT Emergencies
- Epistaxis
Have the patient lean forward and apply firm pressure for 10 to 15 minutes , then use a topical vasoconstrictor (oxymetazoline 0.05%) and cauterize a visible vessel with silver nitrate.
Topical tranexamic acid (for example 500 mg on a pledget) has mixed evidence. A 2013 trial showed better control than anterior packing, but the NoPAC trial (2021) found no reduction in the need for packing compared with placebo.
Packing or balloon devices follow. A posterior bleed needs admission and specialist care.
Lowering blood pressure has not been shown to stop epistaxis. Routine antibiotics for anterior packing are not supported by evidence.
Patients on anticoagulants: decide on reversal based on severity (Section 10.1). Most can continue anticoagulation after local control.
Ear Infections
Acute otitis media (AAP 2013):
High-dose amoxicillin 80 to 90 mg/kg/day in two divided doses.
Amoxicillin-clavulanate if amoxicillin was taken in the past 30 days or the child has otitis-conjunctivitis.
Penicillin allergy: cefdinir, cefuroxime, cefpodoxime, or ceftriaxone 50 mg/kg IM.
Duration: 10 days under 2 years, 7 days for ages 2 to 5, and 5 to 7 days at 6 years and older.
Observation without antibiotics is an option for selected children with nonsevere illness.
Otitis externa: topical drops (for example ofloxacin or ciprofloxacin with or without a steroid). With a perforated eardrum or tympanostomy tubes, use only non-ototoxic fluoroquinolone drops and avoid aminoglycoside-containing drops such as neomycin. Necrotizing (malignant) otitis externa in older adults with diabetes needs IV antipseudomonal therapy and imaging.
Throat and Deep Neck Infections
Streptococcal pharyngitis:
- Regimen Dose
- Penicillin V 500 mg twice daily for 10 days (adults)
- Amoxicillin 50 mg/kg once daily (maximum 1,000 mg) for 10 days
Benzathine penicillin G 1.2 million units IM once (600,000 units if under 27 kg); recent shortages have limited supply
Penicillin allergy Cephalexin (non-severe allergy), clindamycin or azithromycin (macrolide resistance is common)
A single dose of dexamethasone (about 10 mg) speeds pain relief.
Peritonsillar abscess needs drainage and ampicillin-sulbactam or clindamycin. Ludwig angina and deep neck infections need the airway secured first, IV ampicillin-sulbactam (adding vancomycin if MRSA is a risk) and surgical drainage.
Angioedema: Histamine vs. Bradykinin
Feature Histaminergic (allergic) Bradykinin-mediated
Causes Allergens, NSAIDs, contrast ACE inhibitors , sacubitril-valsartan, hereditary angioedema, thrombolytics (especially with ACE inhibitors)
- Urticaria and itching Common Absent
- Epinephrine, antihistamines, steroids Effective (Section 7.3) Little or no effect
Specific therapy Epinephrine Hereditary angioedema: C1 esterase inhibitor (for example 20 units/kg IV) or icatibant 30 mg SC
ACE inhibitor angioedema can occur after years of uneventful use. Management focuses on the airway , often fiberoptic intubation by an expert. A randomized trial of icatibant for ACE inhibitor angioedema was negative, so its use is limited. Fresh frozen plasma has been used in case reports. Stop the ACE inhibitor permanently and record the reaction as an allergy. Angiotensin receptor blockers carry a small cross-risk and are used only with caution.
Vertigo and Sudden Hearing Loss
Benign paroxysmal positional vertigo is treated with a repositioning maneuver (Epley). AAO-HNS (2017) advises against routine meclizine or other vestibular suppressants for it.
Vestibular neuritis can be treated with vestibular suppressants for no more than a few days. Screen every patient with acute continuous vertigo for a posterior circulation stroke.
Sudden sensorineural hearing loss: AAO-HNS (2019) allows oral corticosteroids (for example prednisone 1 mg/kg/day, maximum 60 mg, for 7 to 14 days) within 2 weeks of onset, plus prompt audiology.
- Dental Emergencies
- Dental Pain
The ADA guideline on acute dental pain recommends NSAIDs, alone or combined with acetaminophen , as first-line therapy, for example ibuprofen 400 mg with acetaminophen 1,000 mg. Opioids are reserved for patients who cannot take these drugs or do not respond, in small quantities.
Antibiotics for Dental Pain and Swelling (ADA 2019, endorsed by ACEP)
No antibiotics for pulpitis, apical periodontitis or a localized abscess without systemic involvement. Definitive dental care (drainage, root canal or extraction) is the treatment.
Antibiotics are indicated when there are systemic signs (fever, malaise, lymph node swelling, trismus or spreading swelling) or when definitive care is not immediately available:
Amoxicillin 500 mg three times daily (or penicillin VK 500 mg four times daily) for 3 to 7 days.
Penicillin allergy without anaphylaxis, angioedema or hives: cephalexin 500 mg four times daily.
Penicillin allergy with anaphylaxis, angioedema or hives: azithromycin (500 mg, then 250 mg daily for 4 days) or clindamycin 300 mg four times daily.
If there is no improvement, add metronidazole to amoxicillin or switch to amoxicillin-clavulanate.
Spreading facial or neck swelling, difficulty swallowing or breathing, or trismus is a deep space infection that needs IV therapy and surgery.
Dental Trauma and Bleeding
Avulsed permanent tooth: replant immediately if possible, or store it in milk, saline or a balanced salt solution. Update tetanus. After replantation, the International Association of Dental Traumatology (2020) suggests systemic antibiotics (doxycycline for patients over 12, or penicillin V). Never replant a primary tooth.
Bleeding after extraction: apply firm gauze pressure. In anticoagulated patients, use local measures such as a tranexamic acid mouthwash or soaked gauze before considering reversal.